跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEROQUEL XR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SEROQUEL XR
Approved
STANDARD
SEROQUEL XR
AstraZeneca Pharmaceuticals LP
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f4928b839f4302e2
Company
AstraZeneca Pharmaceuticals LP
Type
Standard
Approval Details
Approval Id
f4928b839f4302e2
Drug Approval Philippines Name
SEROQUEL XR
Product Name
SEROQUEL XR
Registration Number
DR-XY34617
Brand Name
SEROQUEL XR
Generic Name
QUETIAPINE (AS FUMARATE)
Dosage Form
Extended-Release Tablet
Dosage Strength
200 mg
Manufacturer
AstraZeneca Pharmaceuticals LP
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/astrazeneca-pharmaceuticals-lp
Issuance Date
25 March 2025
Expiry Date
15 September 2031
Pharmacologic Category
ANTI-PSYCHOTIC
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f4928b839f4302e2
Type
Standard
Back to Philippines FDA Approvals